JP2010504339A5 - - Google Patents

Download PDF

Info

Publication number
JP2010504339A5
JP2010504339A5 JP2009529269A JP2009529269A JP2010504339A5 JP 2010504339 A5 JP2010504339 A5 JP 2010504339A5 JP 2009529269 A JP2009529269 A JP 2009529269A JP 2009529269 A JP2009529269 A JP 2009529269A JP 2010504339 A5 JP2010504339 A5 JP 2010504339A5
Authority
JP
Japan
Prior art keywords
composition
group
cell surface
surface marker
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009529269A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010504339A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/020628 external-priority patent/WO2008036421A2/en
Publication of JP2010504339A publication Critical patent/JP2010504339A/ja
Publication of JP2010504339A5 publication Critical patent/JP2010504339A5/ja
Pending legal-status Critical Current

Links

JP2009529269A 2006-09-21 2007-09-21 ヒト組織前駆細胞の接着および分化の、レイシ媒介増強 Pending JP2010504339A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84667606P 2006-09-21 2006-09-21
PCT/US2007/020628 WO2008036421A2 (en) 2006-09-21 2007-09-21 Reishi-mediated enhancement of human tissue progenitor cell adhesion and differentiation

Publications (2)

Publication Number Publication Date
JP2010504339A JP2010504339A (ja) 2010-02-12
JP2010504339A5 true JP2010504339A5 (cg-RX-API-DMAC7.html) 2011-11-10

Family

ID=39201125

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009529269A Pending JP2010504339A (ja) 2006-09-21 2007-09-21 ヒト組織前駆細胞の接着および分化の、レイシ媒介増強

Country Status (4)

Country Link
US (1) US20080247989A1 (cg-RX-API-DMAC7.html)
EP (1) EP2099465A4 (cg-RX-API-DMAC7.html)
JP (1) JP2010504339A (cg-RX-API-DMAC7.html)
WO (1) WO2008036421A2 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7687064B2 (en) 2001-08-06 2010-03-30 Academia Sinica Methods and compositions associated with administration of an extract of Ganoderma lucidum
US7135183B1 (en) 2001-08-06 2006-11-14 Academia Sinica Immuno-modulating antitumor activities of Ganoderma lucidum (Reishi) polysaccharides
US8906380B2 (en) * 2005-10-14 2014-12-09 Academia Sinica Fungal immunostimulatory compositions
US20080214442A1 (en) * 2006-09-21 2008-09-04 Alice Yu Anti-Viral Effect of an Extract of Ganoderma Lucidum
US7785600B2 (en) 2007-08-30 2010-08-31 Wyntek Corporation Compositions and methods for treating allergies, auto-immune diseases, and improving skin condition by ganoderma lucidum (reishi) polysaccharides
US7947283B2 (en) 2007-08-30 2011-05-24 Wyntek Corporation Compositions and methods for treating psoriasis by Ganoderma lucidum (Reishi) polysaccharides
US8071105B2 (en) * 2008-04-21 2011-12-06 Academia Sinica Reishi F3 sub fraction polysaccharides and methods of using same
US10159705B2 (en) 2010-06-28 2018-12-25 Stemtech IP Holdings, LLC Methods and compositions for enhancing stem cell mobilization
CA2848521A1 (en) * 2011-11-18 2013-05-23 Stemtech International, Inc. Use of foti to enhance stem cell mobilization and proliferation

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) * 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
DE3886986T2 (de) * 1987-04-28 1994-08-11 Meiji Milk Prod Co Ltd Glykoprotein, Verfahren zu dessen Herstellung und dieses als aktiven Bestandteil enthaltendes immunsuppressives Agens.
DE69934449T2 (de) * 1998-03-12 2007-09-27 Miltenyi Biotech Gmbh Mikrokolonnen-System für Magnettrennung
DE60045095D1 (de) * 1999-12-15 2010-11-25 Amino Up Chemical Co Ltd Ahren zur herstellung derselben und deren anwendung
CN1298740A (zh) * 2000-04-18 2001-06-13 邱晓辉 一种治疗跌打和风湿病的组合物
US6613754B1 (en) * 2000-09-22 2003-09-02 National Yang-Ming University Polysaccharide-based extract from ganoderma, pharmaceutical use thereof, and process for preparing the same
JP4132635B2 (ja) * 2000-10-24 2008-08-13 株式会社玄米酵素 未失活酵素強化組成物
JP4368540B2 (ja) * 2001-05-16 2009-11-18 長岡 均 骨軟化症予防剤
WO2002096450A1 (en) * 2001-05-30 2002-12-05 Wackvom Limited Compositions containing an active fraction isolated from ganoderma lucidum and methods of use
US7687064B2 (en) * 2001-08-06 2010-03-30 Academia Sinica Methods and compositions associated with administration of an extract of Ganoderma lucidum
US7135183B1 (en) * 2001-08-06 2006-11-14 Academia Sinica Immuno-modulating antitumor activities of Ganoderma lucidum (Reishi) polysaccharides
JP3984522B2 (ja) * 2001-09-27 2007-10-03 日本メナード化粧品株式会社 マトリックスメタロプロテアーゼ阻害剤
US6464982B1 (en) * 2001-11-02 2002-10-15 Chinese Herbal Usa, Inc. Herbal immune system stimulant
JP3817223B2 (ja) * 2002-12-19 2006-09-06 Tdk株式会社 薄膜磁気ヘッド及びその製造方法
JP2008517100A (ja) * 2004-10-14 2008-05-22 アカデミア シニカ GanodermaLucidumの抽出物の投与に関連した方法及び組成物
US8906380B2 (en) * 2005-10-14 2014-12-09 Academia Sinica Fungal immunostimulatory compositions

Similar Documents

Publication Publication Date Title
JP2010504339A5 (cg-RX-API-DMAC7.html)
Kawashima Characterisation of dental pulp stem cells: a new horizon for tissue regeneration?
IL212368A (en) Compounds that increase the spread of hematopoietic stem cells, in vitro methods to increase the number of stem and progenitor cells, a population of cells containing striated hematopoietic stem cells, preparations containing it, and the use of said cells in drug production.
MX348491B (es) Tableta a prueba de manipulacion que proporciona liberacion inmediata de fármaco.
HRP20180266T1 (hr) Postupak priprave osnovnog medija za kulturu mezenhimnih matičnih stanica, osnovni medij za kulturu mezenhimnih matičnih stanica, te terapijsko sredstvo za stanice koje se uzgaja i diferencira uz njegovu upotrebu
JP2012532093A5 (cg-RX-API-DMAC7.html)
MX348054B (es) Tableta a prueba de alteracion que proporciona liberacion inmediata del farmaco.
NZ591146A (en) Composition comprising mesenchymal stem cell aggregates wherein the D90 of said aggregates is less than 150 micomills
IN2014DN08862A (cg-RX-API-DMAC7.html)
MY161389A (en) Method for amplifying nk cells
PH12018500371A1 (en) Clinical formulations
WO2009137624A3 (en) Hemangio colony forming cells and non-engrafting hemangio cells
PL2007429T3 (pl) Doustna kompozycja o korzystnym działaniu sercowo-naczyniowym, zawierająca berberynę
NZ597193A (en) Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
JP2011500858A5 (cg-RX-API-DMAC7.html)
SG10201804330YA (en) Engineered high-affinity human t cell receptors
BR112013026363A2 (pt) nanossuspensões de fármaco criodessecadas
WO2007127454A3 (en) Hepatocyte lineage cells
WO2009135905A3 (en) Mesenchymal stem cells and bone-forming cells
MY188227A (en) Settable compositions comprising wollastonite and pumice and methods of use
WO2012141971A3 (en) Methods and compositions for rejuvenation and expansion of stem cells
WO2012148850A3 (en) Radiopaque injectable nucleus hydrogel compositions
MY163476A (en) Oral care compositions
MX2012014013A (es) Sustrato previsto para actuar como un soporte de cultivo para la preparacion particularmente de las superficies deportivas.
IL177244A0 (en) Astaxanthin, esters thereof and compositions containing them, for regulating gene expression, and their use in the manufacture of medicaments